Analyze Diet
Research in veterinary science2006; 82(1); 68-75; doi: 10.1016/j.rvsc.2006.03.008

A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions.

Abstract: Markers of cartilage breakdown enable studying the degradation of cartilage matrix in equine joint pathologies. This study was designed to determine the levels of Coll2-1, a peptide of the triple helix of type II collagen, and Coll2-1NO(2), its nitrated form in the plasma of healthy horses (controls; n=37) and horses suffering from osteochondrosis (n=34). Clinical and arthroscopic scores were attributed reflecting the severity of lesions and were related to the plasma levels of Coll2-1 and Coll2-1NO(2). The median of Coll2-1 was significantly higher in the control group, whereas the mean of Coll2-1NO(2) showed significant elevation in the pathological group. However, the measurement means of scoring classes did not vary significantly. The markers were able to differentiate the group of horses suffering from osteochondrosis from the group of healthy horses. The elevation of Coll2-1NO(2) in the pathological group indicates an inflammation, mediated through reactive oxygen species and/or increased myeloperoxidase activity.
Publication Date: 2006-06-14 PubMed ID: 16780906DOI: 10.1016/j.rvsc.2006.03.008Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study investigates the levels of a peptide known as Coll2-1 and its nitrated form, Coll2-1NO2, in blood samples from healthy horses and those suffering from a joint condition called osteochondrosis. The results show significant differences in levels of these markers between the two groups, suggesting they could be useful for studying joint inflammation and cartilage degradation in horses.

Introduction to the Study

  • The research focuses on the presence and significance of a type II-collagen derived peptide, Coll2-1 and its nitrated form, Coll2-1NO2, as potent markers of inflammation and cartilage degradation in equine, i.e., horses.
  • The condition of interest in this study is osteochondrosis, a joint disease commonly seen in horses that causes inflammation and cartilage degradation.

Methodology

  • The investigators selected and tested plasma samples from 37 healthy horses and 34 horses diagnosed with osteochondrosis.
  • To illustrate the severity of the disease, each horse in the study was assigned clinical and arthroscopic scores.
  • The researchers then examined the relationship between these disease severity scores and the plasma levels of Coll2-1 and Coll2-1NO2.

Key Findings

  • The research found that the median level of the Coll2-1 peptide was significantly higher in the healthy horse group. On the contrary, the mean level of Coll2-1NO2 was notably elevated in the group of horses with osteochondrosis.
  • No significant changes were observed in the mean scores across the scoring classes, implying that the severity of the disease did not markedly influence these levels.
  • Significantly, the markers were able to differentiate between the horses with osteochondrosis and the healthy horses, indicating their potential role as indicators of this disease.
  • An increase in Coll2-1NO2 in the diseased group suggests that inflammation, possibly mediated through reactive oxygen species or heightened myeloperoxidase activity, is taking place due to the condition.

Conclusion and Implications

  • This study indicates that the type II-collagen derived peptide, Coll2-1, and its nitrated form, Coll2-1NO2, could serve as effective markers for the study of joint inflammation and cartilage degradation in horses.
  • The ability of these markers to distinguish horses with osteochondrosis from healthy ones makes them promising tools for the diagnosis, treatment tracking, and understanding of this equine disease in a comprehensive way.

Cite This Article

APA
Gangl M, Serteyn D, Lejeune JP, Schneider N, Grulke S, Peters F, Vila T, Deby-Dupont G, Deberg M, Henrotin Y. (2006). A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Res Vet Sci, 82(1), 68-75. https://doi.org/10.1016/j.rvsc.2006.03.008

Publication

ISSN: 0034-5288
NlmUniqueID: 0401300
Country: England
Language: English
Volume: 82
Issue: 1
Pages: 68-75

Researcher Affiliations

Gangl, M
  • Department of Clinical Sciences, Large Animal Surgery, Faculty of Veterinary Medicine, University of Liège, Sart Tilman B41, B-4000 Liège, Belgium. m.gangl@vet-lyon.fr
Serteyn, D
    Lejeune, J-Ph
      Schneider, N
        Grulke, S
          Peters, F
            Vila, T
              Deby-Dupont, G
                Deberg, M
                  Henrotin, Y

                    MeSH Terms

                    • Animals
                    • Biomarkers / analysis
                    • Cartilage Diseases / diagnosis
                    • Cartilage Diseases / metabolism
                    • Cartilage Diseases / pathology
                    • Cartilage Diseases / veterinary
                    • Collagen Type II / chemistry
                    • Collagen Type II / metabolism
                    • Female
                    • Horse Diseases / diagnosis
                    • Horse Diseases / metabolism
                    • Horse Diseases / pathology
                    • Horses
                    • Inflammation / diagnosis
                    • Inflammation / metabolism
                    • Inflammation / veterinary
                    • Male
                    • Nitro Compounds / metabolism

                    Citations

                    This article has been cited 7 times.
                    1. Marouf BH. Effect of Resveratrol on Serum Levels of Type II Collagen and Aggrecan in Patients with Knee Osteoarthritis: A Pilot Clinical Study. Biomed Res Int 2021;2021:3668568.
                      doi: 10.1155/2021/3668568pubmed: 34805399google scholar: lookup
                    2. Henrotin Y, Patrier S, Pralus A, Roche M, Nivoliez A. Protective Actions of Oral Administration of Bifidobacterium longum CBi0703 in Spontaneous Osteoarthritis in Dunkin Hartley Guinea Pig Model. Cartilage 2021 Dec;13(2_suppl):1204S-1213S.
                      doi: 10.1177/1947603519841674pubmed: 30982336google scholar: lookup
                    3. Turlo AJ, Cywinska A, Frisbie DD. Revisiting predictive biomarkers of musculoskeletal injury in thoroughbred racehorses: longitudinal study in polish population. BMC Vet Res 2019 Feb 26;15(1):66.
                      doi: 10.1186/s12917-019-1799-7pubmed: 30808359google scholar: lookup
                    4. Verwilghen DR, Martens A, Busschers E, Franck T, Deberg M, Henrotin Y, Vanderheyden L, Serteyn D. Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis. Vet Res Commun 2011 Oct;35(7):401-8.
                      doi: 10.1007/s11259-011-9487-5pubmed: 21681550google scholar: lookup
                    5. Verwilghen DR, Vanderheyden L, Franck T, Busoni V, Enzerink E, Gangl M, Lejeune JP, van Galen G, Grulke S, Serteyn D. Variations of plasmatic concentrations of Insulin-like Growth Factor-I in post-pubescent horses affected with developmental osteochondral lesions. Vet Res Commun 2009 Oct;33(7):701-9.
                      doi: 10.1007/s11259-009-9219-2pubmed: 19319655google scholar: lookup
                    6. Bertuglia A, Pallante M, Pagliara E, Valle D, Bergamini L, Bollo E, Bullone M, Riccio B. Determinants of joint effusion in tarsocrural osteochondrosis of yearling Standardbred horses. Front Vet Sci 2024;11:1389798.
                      doi: 10.3389/fvets.2024.1389798pubmed: 39113724google scholar: lookup
                    7. Oh DK, Na HS, Jhun JY, Lee JS, Um IG, Lee SY, Park MS, Cho ML, Park SH. Bifidobacterium longum BORI inhibits pain behavior and chondrocyte death, and attenuates osteoarthritis progression. PLoS One 2023;18(6):e0286456.
                      doi: 10.1371/journal.pone.0286456pubmed: 37352198google scholar: lookup